Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 IMCD Signs Agreement with Evonik - Happi
Company News

IMCD Signs Agreement with Evonik

Will distribute Evonik’s range of sodium and potassium alkoxides.

Evonik and IMCD have reached an agreement on the distribution of Evonik’s range of sodium and potassium alkoxides in UK, Ireland, Nordics, France, Spain, Portugal and The Netherlands.
 
From June 1, 2020, IMCD will distribute the materials into industrial and pharmaceutical markets, supporting existing customers and growing the business further. Omega 3 markets are not included in the agreement.
 
Chris Young, director, regulated synthesis commented, “We are extremely pleased to be working with Evonik, the global leader in sodium and potassium alkoxides. IMCD’s in-depth knowledge of the pharmaceutical and industrial synthesis markets will enable us to serve well the existing customers as well as allowing opportunities to grow the business for this key range of products.”
 
IMCD will market the full range of sodium and potassium alkoxides offered by Evonik. The alkoxides can be used as both reagents and catalysts in applications and markets including pharma & healthcare, flavors & additives and industrial chemical manufacturing.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters